Perylene Diimide Derivatives: From Molecular Engineering to Precision Cancer Theranostics
Luminescence · 2026-06 · 41 (6)
DOI: 10.1002/bio.70511 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Luminescence, online erschienen am 01.06.2026. Verfasst von Xilong Wu und 1 weiteren Autor:innen. Beteiligte Einrichtung: School of Chemistry and Chemical Engineering, Beijing Institute of Technology, Beijing, China. Hauptthemen laut MEDLINE: Perylene, Imides, Neoplasms, Theranostic Nanomedicine. Die Arbeit nennt 115 Literaturangaben.
Abstract (Originalsprache)
Perylene diimide (PDI) derivatives are a class of well‐established organic optoelectronic materials with a rigid π‐conjugated fused ring framework, which have been extensively explored for biomedical applications including fluorescence imaging, photoacoustic imaging, and tumor phototherapy over the past decades. Benefiting from their intrinsic merits, including high fluorescence quantum yield (FQY), tunable photophysical properties, excellent photochemical stability, and facile structural functionalization, PDIs have shown outstanding performance in photodynamic therapy (PDT) and photothermal therapy (PTT). However, the biomedical translation of PDIs still faces critical bottlenecks: insufficient water solubility and severe aggregation‐caused quenching (ACQ) effect derived from strong intermolecular π–π stacking, limited tissue penetration depth from short‐wavelength absorption/emission, tumor microenvironment hypoxia that restricts type II PDT efficacy, and unsatisfactory photothermal conversion efficiency (PCE) of conventional PDI derivatives for PTT. This review systematically summarizes the research progress of PDIs in biomedical fields, focusing on molecular design strategies for spectral redshift, water solubility enhancement, and phototherapeutic performance optimization. Meanwhile, the structure–property relationships of PDI derivatives are elaborated in depth from the perspective of molecular orbital engineering and aggregation state regulation. Finally, existing challenges and future development directions in biomedical translation are discussed to provide guidance for the rational design of high‐performance PDI‐based diagnostic and therapeutic agents.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Chemistry and Chemical Engineering, Beijing Institute of Technology, Beijing, China.
ORCID-Profile: Xilong Wu
Zitieren
APA
Wu, X., & Jing, C. (2026). Perylene Diimide Derivatives: From Molecular Engineering to Precision Cancer Theranostics. Luminescence, 41(6). https://doi.org/10.1002/bio.70511
Vancouver
Wu X, Jing C. Perylene Diimide Derivatives: From Molecular Engineering to Precision Cancer Theranostics. Luminescence. 2026;41(6). doi:10.1002/bio.70511
BibTeX
@article{Wu2026,
author = {Wu, Xilong and Jing, Chaojun},
title = {Perylene Diimide Derivatives: From Molecular Engineering to Precision Cancer Theranostics},
journal = {Luminescence},
year = {2026},
volume = {41},
number = {6},
doi = {10.1002/bio.70511}
}
EUVIMED